NYSE:NVO
Novo Nordisk A/S Stock News
$126.69
-0.600 (-0.471%)
At Close: May 08, 2024
4 Large Drug Stocks to Watch as the Industry Recovers
01:32pm, Thursday, 19'th May 2022 Zacks Investment Research
Drug/biotech companies are likely to see significant advances in innovation in 2022. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Glaxo (GSK) are wor
4 Large Drug Stocks to Watch as the Industry Recovers
11:17am, Thursday, 19'th May 2022
Drug/biotech companies are likely to see significant advances in innovation in 2022. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Glaxo (GSK) are wor
Lilly's (LLY) Diabetes Treatment Tirzepatide Gets FDA Nod
01:28pm, Monday, 16'th May 2022 Zacks Investment Research
Lilly's (LLY) Mounjaro (tirzepatide) is a novel diabetes treatment, which has shown impressive blood sugar reductions and weight loss in a broad range of type II diabetes patients in the SURPASS studi
Novo Reports Q1 2022 Financial Results
09:30pm, Friday, 13'th May 2022 GlobeNewswire Inc.
VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Novo Resources Corp. (“Novo” or the “Company”) (TSX: NVO, NVO.WT & NVO.WT.A) (OTCQX: NSRPF) is pleased to announce its financial
How Novo Nordisk Will Protect Insulin Sales
11:23am, Thursday, 12'th May 2022 The Motley Fool
Advancing insulin technology promises a better patient experience.
How Novo Nordisk Will Protect Insulin Sales
07:23am, Thursday, 12'th May 2022
Advancing insulin technology promises a better patient experience.
High-Grade Gold Mineralized Zone Intersected at Malmsbury Project
01:20pm, Tuesday, 10'th May 2022 GlobeNewswire Inc.
HIGHLIGHTS
3 Unstoppable Stocks to Buy in May
11:03am, Saturday, 07'th May 2022 The Motley Fool
These big drugmakers should be long-term winners.
3 Unstoppable Stocks to Buy in May
07:03am, Saturday, 07'th May 2022
These big drugmakers should be long-term winners.
Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2022 Update
05:44am, Saturday, 07'th May 2022 Seeking Alpha
Ken Fisher’s 13F portfolio value decreased from ~$179B to ~$165B in Q1 2022. Find more details here...
Prothena (PRTA) Q1 Earnings Beat, Pipeline Progress in Focus
04:24pm, Friday, 06'th May 2022 Zacks Investment Research
Prothena beats on earnings and revenues in the first quarter of 2022. The company's progress with its AD pipeline is encouraging.
Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates
03:04pm, Monday, 02'nd May 2022 Zacks Investment Research
Novo Nordisk (NVO) reports better-than-expected results for Q1. Sales are aided by growth in Diabetes and Obesity Care on higher GLP-1 revenues.
3 Top Biotech Stocks To Watch In May 2022
02:30pm, Monday, 02'nd May 2022
Which biotech stocks do you have on your May 2022 watchlist?
Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates
12:47pm, Monday, 02'nd May 2022
Novo Nordisk (NVO) reports better-than-expected results for Q1. Sales are aided by growth in Diabetes and Obesity Care on higher GLP-1 revenues.
The Zacks Analyst Blog Highlights Novo Nordisk, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and Biogen
10:22am, Monday, 02'nd May 2022 Zacks Investment Research
Novo Nordisk, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and Biogen have been included in this Analyst Blog.
